These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30574625)

  • 1. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Watthanasuntorn K; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Keaveny AP; Ungprasert P
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):601-608. PubMed ID: 31567712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Boonpheng B; Panjawatanan P; Sharma K; Ungprasert P; Pungpapong S; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):986-994. PubMed ID: 29787418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2017; 23(6):311-317. PubMed ID: 29205182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
    Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Cheungpasitporn W; Pungpapong S; Lukens FJ; Ungprasert P
    Dig Liver Dis; 2018 Nov; 50(11):1166-1175. PubMed ID: 30292566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
    Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Cheungpasitporn W; Lukens FJ; Harnois DM; Pungpapong S; Ungprasert P
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):211-217. PubMed ID: 32530988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Kroner PT; Cheungpasitporn W; Ungprasert P
    Ann Gastroenterol; 2020; 33(6):661-666. PubMed ID: 33162743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.
    Lapumnuaypol K; Kanjanahattakij N; Pisarcik D; Thongprayoon C; Wijarnpreecha K; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):854-860. PubMed ID: 29697458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1802-1807. PubMed ID: 27029776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Aby ES; Panjawatanan P; Lapumnuaypol K; Cheungpasitporn W; Lukens FJ; Harnois DM; Ungprasert P
    Ann Gastroenterol; 2021; 34(4):568-574. PubMed ID: 34276197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and the risk of urolithiasis: A systematic review and meta-analysis.
    Qin S; Wang S; Wang X; Wang J
    Medicine (Baltimore); 2018 Aug; 97(35):e12092. PubMed ID: 30170429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The severity of NAFLD is associated with the risk of urolithiasis.
    Qin S; Wang J; Zhou C; Zhang Y; Xu Y; Wang X; Wang S
    Br J Biomed Sci; 2019 Apr; 76(2):53-58. PubMed ID: 30430908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Manatsathit W; Jaruvongvanich V; Ungprasert P
    J Clin Gastroenterol; 2018; 52(5):386-391. PubMed ID: 28098578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insomnia and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Ungprasert P
    J Postgrad Med; 2017; 63(4):226-231. PubMed ID: 28862239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis.
    Einollahi B; Naghii MR; Sepandi M
    Endocr Regul; 2013 Jan; 47(1):27-32. PubMed ID: 23363254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.